HemaCare Co. (OTCMKTS:HEMA – Get Free Report) was up 0.6% during mid-day trading on Thursday. The company traded as high as $25.31 and last traded at $25.31. Approximately 5,400 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Performance
The company’s 50-day moving average price is $25.31 and its 200 day moving average price is $25.31.
About HemaCare
HemaCare Corporation was a biotechnology company that provided human-derived biological materials for research and development. Its products included blood components, primary human cells, leukopaks and other donor-derived materials used in cellular therapy, immunotherapy, regenerative medicine and related life sciences research.
The company operated collection centers and worked with qualified donors to supply researchers and biopharmaceutical companies with materials obtained from healthy and disease-state individuals.
See Also
- Five stocks we like better than HemaCare
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
